Screening of High-Risk Families for Pancreatic Cancer

  title={Screening of High-Risk Families for Pancreatic Cancer},
  author={Christopher James Grocock and Matthew J Harcus and John P. Neoptolemos},
  pages={215 - 222}
Purpose of Review: To discuss how to recognise and manage high-risk individuals. Recent Findings: Publication of initial results of screening for pancreatic cancer from US centres. Several masses and premalignant lesions have been detected, but the detection of the first pancreatic cancer through an organised study of screening has yet to be published. There has been progress in risk stratification; the role of diabetes in predisposing for cancer has been characterised and molecular modalities… 

Figures from this paper

Predicting malignancy in pre-neoplastic lesions detected during screening for pancreatic cancer

This work identified a marker which could be used to identify those IPMN which should be resected and those which may be safely observed and found that the presence of p53 mutation in the tissue was a better prognostic marker of survival than the histological diagnosis alone.

Selecting families eligible for pancreatic cancer screening: another brick in the wall for the early detection of pancreatic ductal adenocarcinoma and its precursors.

  • R. PezzilliA. Morselli-Labate
  • Medicine
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2012

Early detection of pancreatic cancer.

Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.

  • S. Urayama
  • Medicine
    World journal of gastroenterology
  • 2015
This work proposes to expand the population of higher risk PDAC group with combination clinical and metabolomics parameters to generate an early PDAC detection screening strategy available for a wider population.

Screening for pancreatic cancer in familial high-risk individuals: A systematic review.

Pancreatic cancer screening in familial HRIs is associated with a higher detection rate and longer survival, although screening may influence psychological function and increase the economic burden.

Pancreatic ductal adenocarcinoma screening: new perspectives.

A need exists to introduce the concept of "early" ductal adenocarcinoma, which must identify the disease in an early stage in order to be effective in screening programs of this deadly disease.

Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature

This is the first study focusing on clinical implementation of advanced testing and what is required for novel technologies in cancer care to be cost‐effective and the model clearly demonstrated the potential of multiplexed proteomic‐testing of PC and also identified the requirements for test accuracy.

Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection

CA19-9 and CA125 have encouraging sensitivity for detecting preclinical pancreatic cancer, and both markers can be used as prognostic tools, and this work challenges the prevailing view that CA19- 9 is upregulated late in the course of pancreaticcancer development.

Clinical Management of Pancreatic Cancer

The only treatment for pancre-atic cancer with curative potential is resection of the involved portion of the pancreas, so with a small subgroup of patients presenting with re-sectable pancreatic cancer at initial diagnosis, the prognosis for this patient population is grim.

Risk Factors in Pancreatic Cancer

Analysis of human pancreas genomes showed that 12 common signaling pathways involved in cellular repair mechanisms, metabolism, cell-cycle regulation, genomic repair, and metastasis are affected in over two thirds of the pancreatic cancer genome, including mainly point mutations.



International Registries of Families at High Risk of Pancreatic Cancer

Purpose: To describe the need for multinational registries of families at high risk of pancreatic cancer and the issues surrounding identification of such families. Results: A consensus position was

Inherited Pancreatic Cancer: Surveillance and Treatment Strategies for Affected Families

The screening and surveillance of high-risk members of familial pancreatic cancer kindreds using EUS and ERCP is an effective method for identifying individuals with pancreatic dysplasia prior to the onset of invasive pancreaticcancer.

Familial pancreatic cancer: a review and latest advances.

Familial Pancreatic Cancer identifies a target group for secondary screening and offers researchers the opportunity to elucidate the early pathogenesis of pancreatic cancer.

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

  • M. CantoM. Goggins A. Kalloo
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2006

Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer

This data indicates that members of this family frequently develop pancreatic endocrine or exocrine insufficiency before cancer is diagnosed; this fact can be used as a clinical marker for family members who are at greatest risk for pancreatic cancer.

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.

  • M. CantoM. Goggins R. Hruban
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2004

Advances in counselling and surveillance of patients at risk for pancreatic cancer

This comprehensive review article summarises the predispositions that put people at a high risk of developing pancreatic cancer and the current status in the counselling and surveillance of these people using not only available medical literature, but also incorporating international expert opinion.

Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis.

It is shown that genetic factors can have a striking effect on the development of pancreatic malignancy and diabetes mellitus and the molecular approach applied here to the early diagnosis of pancreatIC cancer may prove valuable in this family for identification of subjects at risk.

Familial pancreatic cancer.

The histologic appearance of the pancreatic cancer itself, and/or the presence and appearance of precancerous changes in the pancreas, may increase the clinical index of suspicion for a genetic syndrome.

Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups.

Combination molecular analysis increased the discrimination between patients with malignant and benign disease and would allow patients in high-risk groups to be stratified from negligible risk to over 50% probability of an early cancer.